Lantus in Brazil: prescription, pharmacy and pricing
Lantus (Insulin Glargine) is available in Brazil under the regulatory framework of ANVISA (Agência Nacional de Vigilância Sanitária). This page summarises how the medication is prescribed and dispensed locally, what insurance or the public system cover, and which options exist for legally and safely accessing Lantus 100 IU/mL.
- Regulator
- ANVISA (Agência Nacional de Vigilância Sanitária)
- Currency
- BRL
- Active ingredients
- Insulin Glargine
- Available dosages
- 100 IU/mL
Prescription status in Brazil
Brazil uses tarja vermelha (red stripe — prescription only) and tarja preta (black stripe — controlled) labels for prescription medication. Many other medications are free-sale at pharmacies. Lantus contains the active ingredient Insulin Glargine, in the Diabetes Treatment class, and its classification in Brazil follows the standard rules of ANVISA (Agência Nacional de Vigilância Sanitária).
Pharmacy dispensing
Brazilian farmácias and drogarias range from major chains (Drogasil, Pacheco, RaiaDrogasil) to small independents. Pharmacist counsel is common but less central than in Europe. The pharmacist is the most reliable local source of information on stock, authorised substitutions (generic vs brand) and specific precautions for Lantus at the available strengths (100 IU/mL).
Online and tele-prescribing access
Online pharmacy is well-developed in Brazil through chain platforms; ANVISA-licensed channels handle Rx medication with verified prescriptions, while informal online sales of Rx are illegal but exist. Buying Lantus from unauthorised sellers or without local verification exposes the user to counterfeit medication and unmonitored use of Insulin Glargine.
When Lantus is prescribed
The medication is indicated in adults and paediatric patients with type 1 diabetes mellitus, and in adults with type 2 diabetes mellitus when basal insulin is required.
Pricing and availability in BRL
Retail pricing in Brazil depends on the strength (100 IU/mL), whether the original brand or an authorised generic is dispensed, and insurance or public-system coverage. The difference between brand and generic is usually the most meaningful economic lever for ongoing use. Comparing prices at two or more locally authorised pharmacies before first refill is recommended.
Frequently asked questions
Do I need a prescription for Lantus in Brazil? ▾
Brazil uses tarja vermelha (red stripe — prescription only) and tarja preta (black stripe — controlled) labels for prescription medication. Many other medications are free-sale at pharmacies. In practice, Lantus follows the status of its active ingredient Insulin Glargine in the regulatory system of ANVISA (Agência Nacional de Vigilância Sanitária).
Is generic Lantus available in Brazil? ▾
Authorised generics of Insulin Glargine are typically available in Brazil at a lower cost than branded Lantus, with bioequivalence required by ANVISA (Agência Nacional de Vigilância Sanitária). Substitution is handled by the pharmacist under local equivalence rules.
How much does Lantus cost in BRL? ▾
Prices in BRL vary by pharmacy and by strength (100 IU/mL). Authorised generics of Insulin Glargine are usually substantially cheaper than the brand and are the typical economic reference point for ongoing use in Brazil.
Lantus in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- FranceANSM (Agence nationale de sécurité du médicament et des produits de santé)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- CanadaHealth Canada
- South KoreaMFDS (Ministry of Food and Drug Safety)
- JapanPMDA (Pharmaceuticals and Medical Devices Agency)
- AustriaBASG (Federal Office for Safety in Health Care)
- SwitzerlandSwissmedic (Swiss Agency for Therapeutic Products)
- AustraliaTGA (Therapeutic Goods Administration)
- ColombiaInvima (National Food and Drug Surveillance Institute)
- ChileISP (Instituto de Salud Pública de Chile, Public Health Institute)
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.